Thyrocare Technologies Limited (THYROCARE) Financial History

Name: Thyrocare Technologies Limited (THYROCARE) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-09-20

Thyrocare Technologies Limited (THYROCARE) operates in the Diagnostics & Research industry and is headquartered in Navi Mumbai, India with about 1,906 employees. Its market capitalization is roughly ₹88 billion. In the fiscal year ended 2026-03-31, THYROCARE reported ₹8.2B in revenue and ₹1.6B in net income.

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others.

Interactive charts & full statements →

THYROCARE Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹8.2B	₹6.8B	₹5.7B	₹5.2B
Gross Profit	₹6.0B	₹4.9B	₹4.0B	₹3.5B
Operating Income (EBIT)	₹2.0B	₹1.4B	₹927M	₹846M
Net Income	₹1.6B	₹915M	₹708M	₹645M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THYROCARE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹2.4B	₹2.2B	₹2.0B	—	₹1.9B	₹1.9B	—
Gross Profit	₹1.8B	₹1.7B	₹1.5B	—	₹1.4B	₹1.4B	—
Operating Income (EBIT)	₹648M	₹611M	₹362M	—	₹464M	₹439M	—
Net Income	₹522M	₹471M	₹290M	—	₹389M	₹217M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THYROCARE Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹1.5B)	(₹953M)	(₹953M)	(₹794M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

THYROCARE Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹7.5B	₹6.9B	₹6.4B	₹6.3B	—
Total Liabilities	₹1.6B	₹1.5B	₹1.2B	₹975M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive THYROCARE viewer.

Other Companies in Diagnostics & Research

SYNGENE · Syngene International Limited — ₹149 billion
4694 · BML, Inc. — JPY 138 billion
METROPOLIS · Metropolis Healthcare Limited — ₹124 billion
2268 · WuXi XDC Cayman Inc. — HK$98 billion
2395 · Shin Nippon Biomedical Laboratories, Ltd. — JPY 55 billion
3347 · Hangzhou Tigermed Consulting Co., Ltd — HK$39 billion
LONN · Lonza Group AG — CHF 38 billion
4671 · FALCO HOLDINGS Co., Ltd. — JPY 29 billion

← THYP All “T” companies TI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.